טוען...
Convalescent Plasma Therapy for COVID-19: State of the Art
Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging infectious diseases; its efficacy was later associated with the evidence that polyclonal neutralizing antibodies can reduce the duration of viremia. Recent large outbreaks of viral diseases for which effective ant...
שמור ב:
| הוצא לאור ב: | Clin Microbiol Rev |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430293/ https://ncbi.nlm.nih.gov/pubmed/32792417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CMR.00072-20 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|